학술논문

Cost Effectiveness of Dapagliflozin for Heart Failure Across the Spectrum of Ejection Fraction: An Economic Evaluation Based on Pooled, Individual Participant Data From the DELIVER and DAPA-HF Trials
Document Type
Article
Source
In: Journal of the American Heart Association. (Journal of the American Heart Association, 5 March 2024, 13(5))
Subject
Language
English
ISSN
20479980